Neuroscientist Colin Blakemore Dies at 78

The prolific science communicator specialized in studies of vision and brain plasticity and was the focus of threats from animal rights extremists for several years.

Written byLisa Winter
| 2 min read
Colin Blakemore
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Colin Blakemore, a science communicator and pioneering neuroscientist who was among the first researchers to explain brain plasticity, died on June 27 at the age of 78 after receiving hospice care for motor neuron disease, his daughter Sarah-Jayne announced via Twitter.

Born June 1, 1944, in Stratford-Upon-Avon in England, Colin Blakemore showed academic aptitude early on. According to a tribute from the University of Oxford, Blakemore received a state scholarship to attend Cambridge University’s Corpus Christi College. He studied medical sciences and graduated with honors in 1965. He took only two and a half years after his graduation to earn his PhD in physiological optics from the University of California, Berkeley.

At age 24, he became a lecturer at the University of Oxford, where he would later be promoted to professor and fellow. He studied brain development, including binocular depth perception and spatial awareness, showing how vision developed and demonstrating ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Lisa joined The Scientist in 2017. As social media editor, some of her duties include creating content, managing interactions, and developing strategies for the brand’s social media presence. She also contributes to the News & Opinion section of the website. Lisa holds a degree in Biological Sciences with a concentration in genetics, cell, and developmental biology from Arizona State University and has worked in science communication since 2012.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies